Blog
RSS FeedPosted by Michael Wonder on 23 Jan 2026
What role does equity play in Australia’s health technology assessment processes? A review of the PBAC recommendations regarding vaccines
23 January 2026 - The Australian PBAC makes recommendations to the government on the listing of vaccines on the National Immunisation ...
Posted by Michael Wonder on 18 Dec 2025
Update from the PBAC (December 2025)
18 December 2025 - The final PBAC update for 2025 is now available. ...
Posted by Michael Wonder on 13 Dec 2025
PBAC weight loss drug decision imminent
12 December 2025 - Patients are spending as much as $5,000/year on private market GLP-1 therapies – an incoming PBAC recommendation ...
Posted by Michael Wonder on 20 May 2025
Redefining value assessment and healthcare funding priorities for medicines: the journey to patient-centric decision making in APAC – a systematic literature review
14 May 2025 - This study explored patient involvement in health care decision-making in the Asia-Pacific region by identifying roles and ...
Posted by Michael Wonder on 17 Feb 2025
Unravelling the association between uncertainties in model-based economic analysis and funding recommendations of medicines in Australia
14 February 2025 - Health technology assessment is used extensively by the PBAC to inform medicine funding recommendations in Australia. ...
Posted by Michael Wonder on 25 Jun 2024
Update from the PBAC (June 2024)
25 June 2024 - As newly appointed Chair of the PBAC, I would like to take the opportunity to establish ...
Posted by Michael Wonder on 08 Sep 2023
Review of cancer related surrogate outcomes used for PBAC decision-making
8 September 2023 - Surrogate outcome measures have an increasingly important role in cancer medicine research providing evidence to support ...
Posted by Michael Wonder on 29 Aug 2023
Australia knocks back application for diabetes drug that could overshadow Ozempic
29 August 2023 - Australia has knocked back an application to subsidise the diabetes drug Mounjaro but the manufacturer still wants ...
Posted by Michael Wonder on 18 Dec 2022
EQ-5D-Y-3L value sets, valuation methods and conceptual questions
12 December 2022 - The measurement and valuation of child health-related quality of life is a rapidly evolving field. ...
Posted by Michael Wonder on 14 Sep 2022
Has there actually been early resolution for early resolution resubmissions?
15 September 2022 - Following on from this week's article on early re-entry resubmissions, today we took a close look ...
Posted by Michael Wonder on 08 Sep 2022
Large scale population based surveys linked to administrative health databases as a source of data on health utilities in Australia
8 September 2022 - It is ideal that modelling studies apply health utility values that are compatible, derived using common methods, ...
Posted by Michael Wonder on 07 Feb 2022
Analysis of consumer comments into PBAC decision-making (2014–9)
4 February 2022 - Our objective was to analyse and review consumer comments in the PBAC's decision-making process. ...
Posted by Michael Wonder on 09 Sep 2021
Consumers to have more say on medicine access issues
7 September 2021 - Consumer involvement in Australia’s medicines choices has been further strengthened under a new strategic agreement Medicines ...
Posted by Michael Wonder on 24 Jun 2021
Moving patient stories highlight opportunities to strengthen our health care systems for all Australians
24 June 2021 - It was an emotional evening among the nearly 200 in-person and online attendees at Parliament House last ...
Posted by Michael Wonder on 15 Jun 2021
Health care funding decisions and real world benefits: reducing bias by matching untreated patients
14 June 2021 - Governments and health insurers often make funding decisions based on health gains from randomised controlled trials. ...